Table 2. Initial treatment of men diagnosed with T1/T2 cancer.

			Adjusted for
	Black men	White men	Centre (n=947)		Centre and age (n=947)		Centre, age, grade, stage, and comorbidity (n=846)
	n (%)	n (%)	OR (95% CI)	P-value	OR (95% CI)	P-value	OR (95% CI)	P-value
Has T1/T2 cancer	332	663
and initial treatment recorded	314 (95)	633 (95)
No treatment	50 (16)	188 (30)
Hormone therapy	118 (38)	249 (39)
Curative radiotherapy	104 (33)	123 (19)	1.67 (1.20, 2.32)	0.002	0.85 (0.58, 1.23)	0.39	0.77 (0.51, 1.14)	0.19
Curative surgery	42 (13)	73 (12)	1.44 (0.92, 2.27)	0.114	0.67 (0.38, 1.16)	0.15	0.79 (0.42, 1.48)	0.45
Curative radiotherapy or surgery	146 (46)	196 (31)	1.57 (1.17, 2.10)	0.003	0.74 (0.52, 1.05)	0.088	0.71 (0.49, 1.03)	0.074

Abbreviations: CI, confidence interval; OR=odds ratio.

Comparisons are against the combination of no treatment+hormone therapy. Dummy covariates distinguish the five centres, three age groups (44–68, 69–76, and 77–94 years), three groups of Gleason scores (⩽6, 7, and 8+), two stages (T1 and T2), and three groups of Charlson scores (0, 1, and 2+).